Folic acid to reduce neonatal mortality from neural tube disorders

International Journal of Epidemiology

Volumn 39, Issue SUPPL. 1, 2010, Pages

  Blencowe, Hannah ^a   Cousens, Simon ^a   Modell, Bernadette ^b   Lawn, Joy ^c,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Saving Newborn Lives/Save the Children USA ^*  (South Africa)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Dietary supplements; Folic acid; Infant; Neonatal mortality; Neural tube defects; Neural tube defects mortality prevention and control; Newborn; Pregnancy

Indexed keywords

FOLIC ACID; VITAMIN B COMPLEX;

ABNORMALITY; CHILD MORTALITY; COHORT ANALYSIS; DATA SET; DEVELOPING WORLD; FOOD SUPPLEMENTATION; INCOME DISTRIBUTION; LITERATURE REVIEW; META-ANALYSIS; MORBIDITY; NEONATE; PREGNANCY; VITAMIN;

ARTICLE; DRUG EFFECT; HUMAN; LOWEST INCOME GROUP; NEURAL TUBE DEFECT; NEWBORN MORTALITY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; DIET SUPPLEMENTATION; FEMALE; INCIDENCE; MALE; MATERNAL CARE; META ANALYSIS; MORTALITY; NEWBORN; POVERTY; PREGNANCY; PRENATAL CARE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW;

DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; NEURAL TUBE DEFECTS; POVERTY; PRECONCEPTION CARE; PREGNANCY; PRENATAL CARE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; VITAMIN B COMPLEX;

EID: 77951630647     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq028     Document Type: Article

References (65)

1. Kulkarni A, Ehrenkranz RA, Bhandari V. Effect of introduction of synchronized nasal intermittent positivepressure ventilation in a neonatal intensive care unit on bronchopulmonary dysplasia and growth in preterm infants. Am J Perinatol 2006;23:233-40.
2. Jegatheesan P, Keller RL, Hawgood S. Early variableflow nasal continuous positive airway pressure in infants < or =1000 grams at birth. J Perinatol 2006;26: 189-96.
3. The Global Burden of Disease. 2004 update. 2004. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf (13 September 2009, date last accessed).
4. McIntosh N, Helms PJ, Smyth RL (eds). Forfar & Arneil's Textbook of Pediatrics. 6th edn. Churchill Livingstone: Edinburgh, 2003, pp. 902-907.
5. Wyszynski DF (ed). Neural Tube Defects: from Origin to Treatment. US: Oxford University Press, 2006, pp. 250-71.
6. Wald N. Folic acid and the prevention of neural tube defects. Ann N Y Acad Sci 1993;678:112-29.
7. Laurence KM, Carter CO, David PA. Major central nervous system malformations in South Wales. II. Pregnancy factors, seasonal variation, and social class effects. Br J Prev Soc Med 1968;22:212-22.
8. Wasserman CR, Shaw GM, Selvin S, Gould JB, Syme SL. Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health 1998;88: 1674-80.
9. Vrijheid M, Dolk H, Stone D, Abramsky L, Alberman E, Scott JE. Socioeconomic inequalities in risk of congenital anomaly. Arch Dis Child 2000;82:349-52.
10. Little J, Elwood H. Socio-economic status and occupation. In: Elwood JM LJ, Elwood H (eds). Epidemiology and Control of Neural Tube Defects. Oxford: Oxford University Press, 1992, pp. 456-520.
11. Grewal J, Carmichael SL, Song J, Shaw GM. Neural tube defects: an analysis of neighbourhood- and individuallevel socio-economic characteristics. Paediatr Perinat Epidemiol 2009;23:116-24.
12. Chan A, Robertson EF, Haan EA, Keane RJ, Ranieri E, Carney A. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis. Br Med J 1993;307:703-706.
13. Morris JK, Wald NJ. Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004. J Med Screen 2007;14:55-59.
14. Czeizel AE, Dudas I, Metneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet 1994;255:131-39.
15. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992; 41(No. RR-14):1-7.
16. de Benoist B. Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food Nutr Bull 2008;29(2 Suppl):S238-S44.
17. Wild J, Sutcliffe M, Schorah CJ, Levene MI. Prevention of neural-tube defects. Lancet 1997;350:30-31.
18. Custer M, Waller K, Vernon S, O'Rourke K. Unintended pregnancy rates among a US military population. Paediatr Perinat Epidemiol 2008;22:195-200.
19. Botto LD, Lisi A, Robert-Gnansia E et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? Br Med J 2005;330:571.
20. Flour Fortification Initiative. 2009. http://www.sph.emory. edu/wheatflour/countrydata.php (13 September 2009, date last accessed).
21. Wolff T, Witkop CT, Miller T, Syed SB, Force USPST. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S Preventive Services Task Force. Ann Intern Med 2009;150: 632-39.
22. Walker N, Fischer-Walker C, Bryce J, Bahl R, Cousens S. for the writing Review Groups on Intervention Effects Standards for CHERG Reviews of Intervention Effects on Child Survival CHERG. Int J Epidemiol (In press).
23. Atkins D, Best D, Briss PA et al. Grading quality of evidence and strength of recommendations. Br Med J 2004; 328:1490.
24. STATA/IC 10.1. Statistical Program. College Station: TX: STATA Corporation, 2008.
25. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001;3:CD001056.
26. Kirke PN, Daly LE, Elwood JH. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child 1992;67:1442-46.
27. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 1981;282: 1509-11.
28. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338:131-37.
29. Martinez de Villarreal L, Perez JZ, Vazquez PA et al. Decline of neural tube defects cases after a folic acid campaign in Nuevo Leon, Mexico. Teratology 2002;66: 249-56.
30. Zlotogora J, Amitai Y, Leventhal A. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid. Isr Med Assoc J 2006;8: 601-604.
31. Liu S, West R, Randell E et al. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth 2004;4:20.
32. Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002;167:241-45.
33. Czeizel AE, Dobo M, Vargha P. Hungarian cohortcontrolled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol 2004;70: 853-61.
34. Berry RJ, Li Z, Erickson JD et al. Prevention of neuraltube defects with folic acid in China China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-90.
35. Milunsky A, Jick H, Jick SS et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262: 2847-52.
36. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-19.
37. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-45.
38. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6: 219-26.
39. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-61.
40. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-86.
41. Lopez-Camelo JS, Orioli IM, da Graca Dutra M et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A 2005;135:120-25.
42. Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol 2008;82: 211-16.
43. Calvo EB, Biglieri A. Impact of folic acid fortification on women's nutritional status and on the prevalence of neural tube defects. Arch Argent Pediatr 2008;106: 492-98.
44. Williams LJ, Mai CT, Edmonds LD et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002;66:33-39.
45. De Wals P, Rusen ID, Lee NS, Morin P, Niyonsenga T. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol 2003;67:919-23.
46. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002;360: 2047-48.
47. Suleiman AJ, Alasfoor DH, Ruth L, Sullivan K. Impact of Flour Fortification: Lessons from Oman. Consequences and Control of Micronutrient Deficiencies. Istanbul Turkey: Micronutrient Forum, 2007, pp. 16-18.
48. Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol 2006;35:706-18.
49. Bol KA, Collins JS, Kirby RS. National Birth Defects Prevention Network. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics 2006;117:803-13.
50. Cotter AM, Daly SF. Neural tube defects: is a decreasing prevalence associated with a decrease in severity? Eur J Obstet Gynecol Reprod Biol 2005;119:161-63.
51. Modell. Folic Acid: from Research to Public Health Practice. 2004. http://www.iss.it/binary/publ/publi/0426. 1106297851.pdf (9 June 2009, date last accessed).
52. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 2005;116:580-86.
53. Bower C, Eades S, Payne J, D'Antoine H, Stanley F. Trends in neural tube defects in Western Australia in Indigenous and non-Indigenous populations. Paediatr Perinat Epidemiol 2004;18:277-80.
54. Cherian A, Seena S, Bullock RK, Antony AC. Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet 2005; 366:930-31.
55. Mahadevan B, Bhat BV. Neural tube defects in Pondicherry. Indian J Pediatr 2005;72:557-59.
56. Verma IC. High frequency of neural-tube defects in North India. Lancet 1978;1:879-80.
57. Imhoff-Kunsch B, Flores R, Dary O, Martorell R. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J Nutr 2007;137:1017-22.
58. Bukowski R, Malone FD, Porter FT et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med 2009;6:e1000061.
59. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. Br Med J 2009;338:b1673.
60. Yang Q, Cogswell ME, Hamner HC et al. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr 2009;91:64-72.
61. Yeung L, Yang Q, Berry RJ. Contributions of total daily intake of folic acid to serum folate concentrations. JAMA 2008;300:2486-87.
62. Hirsch S, Sanchez H, Albala C et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol 2009;21:436-39.
63. Osterhues A. Shall we put the world on folate? Lancet 2009;374:959-61.
64. Cole BF, Baron JA, Sandler RS et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-59.
65. Mason JB, Dickstein A, Jacques PF et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16:1325-29.